Zhelezodefitsitnaya anemiya pri zabolevaniyakh zheludochno-kishechnogo trakta


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article discusses the problem of iron deficiency anemia (IDA), which develops against the background of many diseases, including gastrointestinal diseases. The data on the causes of IDA, pathogenesis, symptoms, diagnosis and treatment of this disease are presented. Particular attention is paid to the drug Ferinject (ferric carboxymaltosate) used for the treatment of IDA in patients with inflammatory bowel diseases.

全文:

受限制的访问

作者简介

D. Abdurakhmanov

Email: abdjamal@mail.ru

参考

  1. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004;53:1190-97.
  2. Clark SF. Iron deficiency anemia. Nutr Clin Pract 2008;23:128-41.
  3. Alleyne M, Horne MK, Miller JL. Individualized treatment for iron-deficiency anemia in adults. Am J Med 2008;121:94348.
  4. Simovich M, Hainsworth LN, Fields PA, et al. Localization of the iron transport proteins Mobilferrin and DMT-1 in the duodenum: the surprising role of mucin. Am J Hematol 2003;74:32-45.
  5. Umbreit J. Iron deficiency: a concise review. Am J Hematol 2005;78:225-31.
  6. Guidi GC, Santonastaso CL. Advancements in anemias related to chronic conditions. Clin Chem Lab Med 2010;48(9):1217-26.
  7. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological Perspective. Dig Dis Sci 2010;55:548-59.
  8. Stroehlein JR, Fairbanks VF, McGill DB, Go VL. Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis 1976;21;841-44.
  9. Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology 2007; 133:1697-717.
  10. Pasricha SS, Flecknoe-Brown SC, Allen KJ, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. MJA 2010; 193:525-32.
  11. Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008;103:1182-92.
  12. Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005;40:1058-65.
  13. Schroder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel diseaseea randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005;100:2503-509. угрожающей жизни (анемической коме) или тяжелой анемии (Hb № 60 г/л), сопровождающейся признаками декомпенсации.
  14. Evstatiev R, Marteau F, Iqbal T, et al. FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease. Gastroenterology 2011;141:846-53.
  15. Van Wyck DB, Martens MG, Seid MH, et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007;110:267-78.
  16. Van Wyck DB, Mangione A, Morrison J, et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009;49:2719-28.
  17. Bailie GR. Efficacy and safety of ferric carboxy-maltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung 2010;60:386-98.
  18. Evenepoel P, Bako GC, Toma C. Intravenous (i.v.) ferric carboxymaltose (FCM) versus i.v. iron sucrose (ISC) in the treatment of iron deficiency anemia (IDA) in patients undergoing maintenance haemodialysis (HD). J Am Soc Nephrol Abstracts Issue 2009;20:665A.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##